Alpha DNA Investment Management’s Invesco BulletShares 2023 Corporate Bond ETF BSCN Stock Holding History
Bought
Maintained
Sold
Other funds holding BSCN
HPC
MFWM
OA
BCM
SFG
Alpha DNA Investment Management's BSCN Position: Q2 2021 in Review
Alpha DNA Investment Management sold out of Invesco BulletShares 2023 Corporate Bond ETF (BSCN) in Q2 2021, closing a stake of 300 shares — an estimated $6K sold.
Alpha DNA Investment Management first reported a position in BSCN in Q4 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 264 funds tracked by Wall St. Rank hold BSCN as of Q2 2021.
- Alpha DNA Investment Management reported no remaining Invesco BulletShares 2023 Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
- Alpha DNA Investment Management sold 300 Invesco BulletShares 2023 Corporate Bond ETF shares in Q2 2021, an estimated $6K.
- Alpha DNA Investment Management first reported a position in Invesco BulletShares 2023 Corporate Bond ETF in Q4 2020 and held it in 2 quarters.
- Alpha DNA Investment Management's Invesco BulletShares 2023 Corporate Bond ETF position peaked at $6K in Q1 2021.
- 264 funds tracked by Wall St. Rank held Invesco BulletShares 2023 Corporate Bond ETF as of Q2 2021.
Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.